Brett J Kopina1, Sophia Missoury2, Bruno Collinet2,3, Mark G Fulton1, Charles Cirio2, Herman van Tilbeurgh2, Charles T Lauhon1. 1. Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, WI 53705, USA. 2. Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France. 3. Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie (IMPMC), Sorbonne-Université, UMR7590 CNRS, MNHN, Paris, France.
Abstract
The tRNA modification N6-threonylcarbamoyladenosine (t6A) is universally conserved in all organisms. In bacteria, the biosynthesis of t6A requires four proteins (TsaBCDE) that catalyze the formation of t6A via the unstable intermediate l-threonylcarbamoyl-adenylate (TC-AMP). While the formation and stability of this intermediate has been studied in detail, the mechanism of its transfer to A37 in tRNA is poorly understood. To investigate this step, the structure of the TsaBD heterodimer from Escherichia coli has been solved bound to a stable phosphonate isosteric mimic of TC-AMP. The phosphonate inhibits t6A synthesis in vitro with an IC50 value of 1.3 μM in the presence of millimolar ATP and L-threonine. The inhibitor binds to TsaBD by coordination to the active site Zn atom via an oxygen atom from both the phosphonate and the carboxylate moieties. The bound conformation of the inhibitor suggests that the catalysis exploits a putative oxyanion hole created by a conserved active site loop of TsaD and that the metal essentially serves as a binding scaffold for the intermediate. The phosphonate bound crystal structure should be useful for the rational design of potent, drug-like small molecule inhibitors as mechanistic probes or potentially novel antibiotics.
The tRNA modification N6-threonylcarbamoyladenosine (n class="Chemical">t6A) is universally conserved in all organisms. In bacteria, the biosynthesis of t6A requires four proteins (TsaBCDE) that catalyze the formation of t6A via the unstable intermediate l-threonylcarbamoyl-adenylate (TC-AMP). While the formation and stability of this intermediate has been studied in detail, the mechanism of its transfer to A37 in tRNA is poorly understood. To investigate this step, the structure of the TsaBD heterodimer from Escherichia coli has been solved bound to a stable phosphonate isosteric mimic of TC-AMP. The phosphonate inhibits t6A synthesis in vitro with an IC50 value of 1.3 μM in the presence of millimolar ATP and L-threonine. The inhibitor binds to TsaBD by coordination to the active site Zn atom via an oxygen atom from both the phosphonate and the carboxylate moieties. The bound conformation of the inhibitor suggests that the catalysis exploits a putative oxyanion hole created by a conserved active site loop of TsaD and that the metal essentially serves as a binding scaffold for the intermediate. The phosphonate bound crystal structure should be useful for the rational design of potent, drug-like small molecule inhibitors as mechanistic probes or potentially novel antibiotics.
Authors: Patrick C Thiaville; Basma El Yacoubi; Caroline Köhrer; Jennifer J Thiaville; Chris Deutsch; Dirk Iwata-Reuyl; Jo Marie Bacusmo; Jean Armengaud; Yoshitaka Bessho; Collin Wetzel; Xiaoyu Cao; Patrick A Limbach; Uttam L RajBhandary; Valérie de Crécy-Lagard Journal: Mol Microbiol Date: 2015-10-07 Impact factor: 3.501
Authors: Jennifer I Handford; Bérengère Ize; Grant Buchanan; Gareth P Butland; Jack Greenblatt; Andrew Emili; Tracy Palmer Journal: J Bacteriol Date: 2009-04-17 Impact factor: 3.490
Authors: Adeline Pichard-Kostuch; Wenhua Zhang; Dominique Liger; Marie-Claire Daugeron; Juliette Létoquart; Ines Li de la Sierra-Gallay; Patrick Forterre; Bruno Collinet; Herman van Tilbeurgh; Tamara Basta Journal: RNA Date: 2018-04-12 Impact factor: 4.942
Authors: William Swinehart; Christopher Deutsch; Kathryn L Sarachan; Amit Luthra; Jo Marie Bacusmo; Valérie de Crécy-Lagard; Manal A Swairjo; Paul F Agris; Dirk Iwata-Reuyl Journal: RNA Date: 2020-05-08 Impact factor: 4.942